… SABA use in excess of recommended limits has been strongly associated with increased …
how SABA and ICS use is defined in the peer-reviewed literature, identify broad patterns in the …

… A consistent pattern of high SABA use from the SABINA … short-acting β 2 -agonists (SABAs)
for use as needed for symptom … that the long-acting β 2 -agonist formoterol component has a …

… there is a consistent association with the use of nebulized β 2 -agonists. Nebulized and oral
… choice in how they use their medications, to perhaps best suit the pattern of their illness and …

… three puffs per day) compared with summer months, when the use of the reliever was
substantially reduced. These usage patterns were linked by patients to viral infections in winter (eg …

… Short-term studies have associated high use of short-acting β 2 -agonists (SABA) with
increased risk of exacerbations, … Patterns of SABA and ICS use during 12-year follow-up …

… However, until 2019, the Global Initiative for Asthma (GINA) recommended the use of
short-acting β 2 -agonist (SABA) reliever monotherapy as step 1 treatment for patients with mild …

… The aim of the SABINA programme is to describe asthma medication prescription patterns, …
Associations between baseline short-acting β 2 -agonist (SABA) use and treatment step and …

… with no use at … β 2 -agonist use and an increased risk for fatal and near-fatal asthma attacks
(6, 7, 121-123). It could also explain the pattern of escalating β 2 -agonist use or β 2 -agonist “…

… -acting β 2 -agonists is apparent despite use of inhaled … Use of small, inhaled doses of
highly selective β 2 -agonists was expected to result in preferential activation of pulmonary β 2 -…

… use on a large scale. Biochemical measures are invasive, expensive and provide no information
about usage patterns … Examining pharmacy records of dispensing patterns is regarded …